Close Menu

NEW YORK – Oxford Immunotec said Tuesday that its third quarter revenues rose 32 percent year over year, driven in part by strong Asia-Pacific sales and an expanding tuberculosis testing market.

For the three months ended Sept. 30, the firm logged $21.2 million in revenues compared to $16.1 million in the year-ago quarter, beating analysts' average estimate for $20.3 million. On a constant currency basis, year-over-year revenue growth was 31 percent.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.